Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 13 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Evaluate Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Rochester, MN

  2. PB to Treat Hereditary Nephrogenic Diabetes Insipidus, ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

    Jacksonville, FL

  3. Cystic Kidney and Liver Disease Biobank

    Rochester, MN

  4. A Study to Analyze Metabolic Fingerprinting in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Controls

    Rochester, MN

  5. Prospective Tissue Collection of Hepatic Epithelia:

    Rochester, MN

  6. Homocysteine Metabolism and Endothelial Function in ADPKD

    Rochester, MN

  7. A Study to Evaluate the Nrf2 Response in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Rochester, MN

  8. A Study to Evaluate the Intrarenal Microvessels in Autosomal Dominant Polycystic Kidney Disease

    Rochester, MN

  9. Regulus Biomarker

    Rochester, MN

  10. A Study to Evaluate the Role of NOX4 and Related Biomarkers in Autosomal Dominant Polycystic Kidney Disease

    Rochester, MN

.

Mayo Clinic Footer